These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 21127316)
1. Predicting EQ-5D utility scores from the Seattle Angina Questionnaire in coronary artery disease: a mapping algorithm using a Bayesian framework. Wijeysundera HC; Tomlinson G; Norris CM; Ghali WA; Ko DT; Krahn MD Med Decis Making; 2011; 31(3):481-93. PubMed ID: 21127316 [TBL] [Abstract][Full Text] [Related]
2. Mapping the Seattle Angina Questionnaire to EQ-5D-5L in patients with coronary heart disease. Li C; Dou L; Fu Q; Li S Health Qual Life Outcomes; 2023 Jul; 21(1):64. PubMed ID: 37400827 [TBL] [Abstract][Full Text] [Related]
3. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Goldsmith KA; Dyer MT; Buxton MJ; Sharples LD Health Qual Life Outcomes; 2010 Jun; 8():54. PubMed ID: 20525323 [TBL] [Abstract][Full Text] [Related]
4. Generating EQ-5D-3L Utility Scores from the Dermatology Life Quality Index: A Mapping Study in Patients with Psoriasis. Davison NJ; Thompson AJ; Turner AJ; Longworth L; McElhone K; Griffiths CEM; Payne K; Value Health; 2018 Aug; 21(8):1010-1018. PubMed ID: 30098665 [TBL] [Abstract][Full Text] [Related]
5. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly. Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359 [TBL] [Abstract][Full Text] [Related]
6. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis. Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745 [TBL] [Abstract][Full Text] [Related]
7. Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature. Wijeysundera HC; Farshchi-Zarabi S; Witteman W; Bennell MC Clinicoecon Outcomes Res; 2014; 6():253-68. PubMed ID: 24876788 [TBL] [Abstract][Full Text] [Related]
8. Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study. James MT; Wilton SB; Clement FM; Ghali WA; Knudtson ML; Tan Z; Tonelli M; Hemmelgarn BR; Norris CM; J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27436303 [TBL] [Abstract][Full Text] [Related]
9. Quantifying Parameter Uncertainty in EQ-5D-3L Value Sets and Its Impact on Studies That Use the EQ-5D-3L to Measure Health Utility: A Bayesian Approach. Pullenayegum EM; Chan KK; Xie F Med Decis Making; 2016 Feb; 36(2):223-33. PubMed ID: 26139449 [TBL] [Abstract][Full Text] [Related]
10. Mapping PROMIS Global Health Items to EuroQol (EQ-5D) Utility Scores Using Linear and Equipercentile Equating. Thompson NR; Lapin BR; Katzan IL Pharmacoeconomics; 2017 Nov; 35(11):1167-1176. PubMed ID: 28710740 [TBL] [Abstract][Full Text] [Related]
11. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372 [TBL] [Abstract][Full Text] [Related]
12. Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis. Chen G; Garcia-Gordillo MA; Collado-Mateo D; Del Pozo-Cruz B; Adsuar JC; Cordero-Ferrera JM; Abellán-Perpiñán JM; Sánchez-Martínez FI Patient; 2018 Dec; 11(6):665-675. PubMed ID: 29876865 [TBL] [Abstract][Full Text] [Related]
13. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores. Kay S; Ferreira A Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628 [TBL] [Abstract][Full Text] [Related]
14. Mapping the EQ-5D index from the cystic fibrosis questionnaire-revised using multiple modelling approaches. Acaster S; Pinder B; Mukuria C; Copans A Health Qual Life Outcomes; 2015 Mar; 13():33. PubMed ID: 25879833 [TBL] [Abstract][Full Text] [Related]
15. Mapping the COPD Assessment Test onto EQ-5D. Hoyle CK; Tabberer M; Brooks J Value Health; 2016 Jun; 19(4):469-77. PubMed ID: 27325339 [TBL] [Abstract][Full Text] [Related]
16. Bayesian statistical models to estimate EQ-5D utility scores from EORTC QLQ data in myeloma. Kharroubi SA; Edlin R; Meads D; McCabe C Pharm Stat; 2018 Jul; 17(4):358-371. PubMed ID: 29460413 [TBL] [Abstract][Full Text] [Related]
17. Mapping Kansas City cardiomyopathy, Seattle Angina, and minnesota living with heart failure to the MacNew-7D in patients with heart disease. Senanayake S; Uchil R; Sharma P; Parsonage W; Kularatna S Qual Life Res; 2024 Aug; 33(8):2151-2163. PubMed ID: 38839680 [TBL] [Abstract][Full Text] [Related]
18. Mapping a patient-reported functional outcome measure to a utility measure for comparative effectiveness and economic evaluations in older adults with low back pain. Rundell SD; Bresnahan BW; Heagerty PJ; Comstock BA; Friedly JL; Jarvik JG; Sullivan SD Med Decis Making; 2014 Oct; 34(7):873-83. PubMed ID: 24829274 [TBL] [Abstract][Full Text] [Related]
19. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061 [TBL] [Abstract][Full Text] [Related]
20. Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease. Young MK; Ng SK; Mellick G; Scuffham PA Qual Life Res; 2013 Jun; 22(5):1065-72. PubMed ID: 22782690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]